India  

COVID:19: Samsung Biologics signs vaccine production deal with Moderna

Zee News Sunday, 23 May 2021
The deal is expected to contribute to the stable and speedy supply of the Moderna vaccine in South Korea.
0
shares
ShareTweetSavePostSend
 
Video Credit: Reuters - Politics - Published
News video: Moderna to seek COVID vaccine authorization for teens

Moderna to seek COVID vaccine authorization for teens 01:23

Moderna's COVID-19 vaccine was found to be effective in adolescents aged 12-17 and showed no new or major safety problems in a clinical trial, the developer said on Tuesday, potentially setting the stage for a second vaccine for school-aged children to be authorized in July. This report produced by...

You Might Like


Related videos from verified sources

Moderna Says Its COVID-19 Vaccine Is Safe and Effective in 12- to 17-Year-Olds [Video]

Moderna Says Its COVID-19 Vaccine Is Safe and Effective in 12- to 17-Year-Olds

On Tuesday, Moderna announced the results of their Phase 2 trial of the administration of their COVID-19 vaccine to children ages 12 to 17

Credit: Cover Video STUDIO     Duration: 01:01Published
Florida Could Soon Be Using Moderna Vaccine On Kids After Successful Clinical Trials [Video]

Florida Could Soon Be Using Moderna Vaccine On Kids After Successful Clinical Trials

CBS4's Keith Jones has more on the local vaccination efforts. Read more: https://cbsloc.al/3wz8x0B

Credit: CBS4 Miami     Duration: 03:37Published
Moderna Announces COVID-19 Vaccine 100% Effective In Children As Young As 12 [Video]

Moderna Announces COVID-19 Vaccine 100% Effective In Children As Young As 12

CBS4's Keith Jones reports on the major vaccine milestone.

Credit: CBS4 Miami     Duration: 02:54Published

Related news from verified sources

Samsung Biologics signs vaccine production deal with Moderna


newKerala.com